JP2013544069A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544069A5
JP2013544069A5 JP2013512280A JP2013512280A JP2013544069A5 JP 2013544069 A5 JP2013544069 A5 JP 2013544069A5 JP 2013512280 A JP2013512280 A JP 2013512280A JP 2013512280 A JP2013512280 A JP 2013512280A JP 2013544069 A5 JP2013544069 A5 JP 2013544069A5
Authority
JP
Japan
Prior art keywords
cyclin
family
nuclear reprogramming
proteins
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013512280A
Other languages
English (en)
Japanese (ja)
Other versions
JP5888753B2 (ja
JP2013544069A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/076017 external-priority patent/WO2012060473A1/en
Publication of JP2013544069A publication Critical patent/JP2013544069A/ja
Publication of JP2013544069A5 publication Critical patent/JP2013544069A5/ja
Application granted granted Critical
Publication of JP5888753B2 publication Critical patent/JP5888753B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013512280A 2010-11-04 2011-11-04 効率的な人工多能性幹細胞の樹立方法 Active JP5888753B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41017810P 2010-11-04 2010-11-04
US61/410,178 2010-11-04
PCT/JP2011/076017 WO2012060473A1 (en) 2010-11-04 2011-11-04 Method of efficiently establishing induced pluripotent stem cells

Publications (3)

Publication Number Publication Date
JP2013544069A JP2013544069A (ja) 2013-12-12
JP2013544069A5 true JP2013544069A5 (enExample) 2014-12-18
JP5888753B2 JP5888753B2 (ja) 2016-03-22

Family

ID=46024582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013512280A Active JP5888753B2 (ja) 2010-11-04 2011-11-04 効率的な人工多能性幹細胞の樹立方法

Country Status (4)

Country Link
US (1) US9637732B2 (enExample)
EP (1) EP2635678A4 (enExample)
JP (1) JP5888753B2 (enExample)
WO (1) WO2012060473A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3260140B1 (en) 2011-12-05 2021-02-03 Factor Bioscience Inc. Methods and products for transfecting cells
US8497124B2 (en) 2011-12-05 2013-07-30 Factor Bioscience Inc. Methods and products for reprogramming cells to a less differentiated state
CA2890110C (en) 2012-11-01 2023-05-02 Factor Bioscience Inc. Methods and products for expressing proteins in cells
KR102415811B1 (ko) 2014-01-31 2022-07-04 팩터 바이오사이언스 인크. 핵산 제조 및 송달을 위한 방법 및 산물
US11241505B2 (en) 2015-02-13 2022-02-08 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
RU2741786C2 (ru) 2016-05-25 2021-01-28 Энсэрм (Энститю Насьональ Де Ла Санте Э Де Ла Решерш Медикаль) Способы и композиции для лечения опухолей
IL264439B2 (en) 2016-08-17 2024-08-01 Factor Bioscience Inc non-viral, cell-free composition comprising a synthetic messenger RNA (MRNA) encoding a gene-editing protein for use in treating cancer, and a synthetic RNA encoding a gene-editing protein for use in treatment
IL314506A (en) 2017-11-24 2024-09-01 Inst Nat Sante Rech Med Methods and preparations for the treatment of cancer
US12599662B2 (en) 2018-08-06 2026-04-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating cancers
EP3969571A4 (en) 2019-05-14 2023-05-24 Aleph Farms Ltd. PLURIPOTENTE CELL AGGREGATES AND THEIR USE
CA3145425A1 (en) 2019-07-03 2021-01-07 Factor Bioscience Inc. Cationic lipids and uses thereof
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
WO2021092657A1 (en) 2019-11-13 2021-05-20 Monash University Methods for reprogramming cells
AU2021389671A1 (en) 2020-11-24 2023-06-22 Monash University Induced stem cells
US12060581B2 (en) 2020-11-24 2024-08-13 Monash University Methods and cellular structures
WO2022207889A1 (en) 2021-04-01 2022-10-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ307399A0 (en) 1999-09-24 1999-10-21 Luminis Pty Limited Cell cycle control
US9567591B2 (en) * 2003-05-15 2017-02-14 Mello Biotechnology, Inc. Generation of human embryonic stem-like cells using intronic RNA
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
MX348010B (es) 2007-04-07 2017-05-23 Whitehead Inst Biomedical Res Reprogramacion de celulas somaticas.
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
JP5945385B2 (ja) * 2008-01-16 2016-07-05 リン、シー−ランLIN, Shi−Lung 誘導性組換えｒｎａ因子を用いた腫瘍のない多能性胚性幹様細胞の生成
JP2011525794A (ja) * 2008-06-26 2011-09-29 国立大学法人大阪大学 ｉＰＳ細胞の製造方法および製造キット
CA2695590C (en) 2008-06-27 2018-01-09 Kyoto University Method of efficiently establishing induced pluripotent stem cells
US9238797B2 (en) 2008-07-07 2016-01-19 Takara Bio Inc. Method for production of pluripotent stem cell

Similar Documents

Publication Publication Date Title
JP2011525793A5 (enExample)
JP2011529330A5 (enExample)
JP2012518988A5 (enExample)
JP2013517758A5 (enExample)
JP2015506673A5 (enExample)
JP2010158171A5 (enExample)
JP2018508198A5 (enExample)
EA201490703A1 (ru) Белковые каркасы на основе фибронектинового повтора типа iii с альтернативными поверхностями связывания
Wu et al. An implicit-gradient-enhanced incremental-secant mean-field homogenization scheme for elasto-plastic composites with damage
EA201892774A1 (ru) Антитела
JP2013505701A5 (enExample)
EP3532075A4 (en) VIRAL METHODS OF MANUFACTURING GENETICALLY MODIFIED CELLS
EP3614470A4 (en) ADHESIVE FOR LITHIUM-ION ELECTRODE, ELECTRODE FOR LITHIUM-ION BATTERY AND ELECTRODE MANUFACTURING PROCESS FOR LITHIUM-ION BATTERY
EP2866284C0 (en) METHOD AND DEVICE FOR MANUFACTURING REACTIVE AGGLOMERATED PARTICLES, METHOD FOR MANUFACTURING ACTIVE SUBSTANCE FOR LITHIUM-ION BATTERY, AND LITHIUM-ION BATTERY AND METHOD FOR MANUFACTURING THE SAME
WO2014204939A3 (en) Methods for quantitative determination of protein-nucleic acid interactions in complex mixtures
WO2009061442A8 (en) Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells
EP2626921A4 (en) BATTERY ELEMENT ASSEMBLY, HEAT EXCHANGER, AND METHOD FOR MANUFACTURING THE HEAT EXCHANGER
JP2011182800A5 (enExample)
EA201492202A1 (ru) Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк
MX372950B (es) Anticuerpos.
DE112019006656A5 (de) Batteriezellenmodul, positioniervorrichtung zur herstellung von batteriezellenmodulen und verfahren zur herstellung von batteriezellenmodulen
BR112014029274A2 (pt) anticorpo isolado, composição farmacêutica, uso do anticorpo, método para tratar infecção rábica, kit para tratar infecção rábica, kit para detectar vírus rábico, ácido nucleico isolado, e, célula hospedeira.
BRPI0908381A2 (pt) Sequência de ácido nucleico, transportador de ácido tricarboxílico mitocondrial, método para a produção de ácido itacônico, célula hospedeira, e, usos de uma proteína e da combinação de uma proteína com a enzima cad, e/ou um transportador mfs
EP2295538A4 (en) METHOD FOR PRODUCING A PLURIPOTENT STEM CELL
JP2014501620A5 (enExample)